| Term 
 
        | How is cystic fibrosis inherited? |  | Definition 
 
        | An autosomal recessive disorder - carriers have no symptoms. Mother is usually tested **Genetic testing, and sweat chloride test > 60
 |  | 
        |  | 
        
        | Term 
 
        | What causes cystic fibrosis? |  | Definition 
 
        | Abnormality in CFTR, a chloride channel, on chromosome 7. F508 most common mutation. - Cl accumulates in ductul lumen of skin, very salty sweat
 - Lung - Cl accumulates in lumen, fluid/secretions build up
 - Pancreas - malabsorption and diabetes
 - Intestines - increased secretion can block
 - Liver - Cirrhosis leads to varices and portal HTN
 - Sweat glands - NaCl excreted --> hyponatremia
 - Reproduction - obstruction leads to infertility
 |  | 
        |  | 
        
        | Term 
 
        | How does CF affect the lungs? |  | Definition 
 
        | Most likely to kill Inflammation, infection, and obstruction
 Measured by FEV1 - Mild (70-89), Moderate (40-69), and severe (less than 40)
 |  | 
        |  | 
        
        | Term 
 
        | What bacteria can colonize a CF patient? |  | Definition 
 
        | - Pseudomonas aeruginosa** most common - Staph aureus - MSSA or MRSA
 - H. influenza - vaccinated against
 - B. cepacia - uncommon, a negative indicator.
 |  | 
        |  | 
        
        | Term 
 
        | How does cystic fibrosis affect the GI tract? |  | Definition 
 
        | - Exocrine - 90%. Deficiency in pancreatic enzymes and fat soluble vitamins - must be supplemented - Endocrine - diabetes. ketoacidosis rare.
 |  | 
        |  | 
        
        | Term 
 
        | What are signs/symptoms of cystic fibrosis? |  | Definition 
 
        | - Pulmonary - Cough, increased sputum, pneumonia, SoB/Dyspnea - GI/endocrine - meconium ileus, pain/distention, N/V, steatorrhea, malnutrition, hyperglycemia
 |  | 
        |  | 
        
        | Term 
 
        | What agents are used for pulmonary symptoms of cystic fibrosis? |  | Definition 
 
        | - Ivacaftor/Kalydeco - only for G551D mutation. 150 mg BID with high fat meals. A CFTR potentiator - Dornase alfa/Pulmozyme - a mucolytic via nebulizer. Loosens sputum
 - Hypertonic 3 or 7% saline - a mucolytic via nebulizer
 - Tobramycin/TOBI - inhaled to prevent PSEUDOMONAS. Month on, month off
 - Aztreonam/Cayston - inhaled to prevent pseudomonas, month on month off
 - Azithromycin/Zithromax - does not cover pseudomonas, pleiotropic
 |  | 
        |  | 
        
        | Term 
 
        | How are GI symptoms improved in cystic fibrosis patients? |  | Definition 
 
        | - Pancreatic enzymes/Creon or Zenpep - reduces fat in stool. Aids in digestion. |  | 
        |  | 
        
        | Term 
 
        | How is a cystic fibrosis exacerbation treated? |  | Definition 
 
        | Look for oxacillin resistance. Is it MRSA? - Double coverage for Pseudomonas aeruginosa - beta lactam + aminoglycoside OR FQN OR Colistin
 - MRSA? Add Vancomycin or Linezolid/Zyvox
 |  | 
        |  | 
        
        | Term 
 
        | What are pharmacokinetic considerations in cystic fibrosis patients? |  | Definition 
 
        | - Increased clearance - Increased Vd
 - Increased metabolism
 - Decreased lung penetration
 **INCREASED DOSES
 |  | 
        |  |